Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla A Blumentritt

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|June 26, 2013
Restrictive Streptomycin Resistance Mutations Decrease the Formation of Attaching and Effacing Lesions in Escherichia coli O157:H7 StrainsChun Chen, Carla A Blumentritt, Meredith M Curtis, et al.
Clinical and Vaccine Immunology : CVI|March 28, 2014
A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsisWildaliz Nieves, Hailey Petersen, Barbara M Judy, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 8, 2014
A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia malleiAnthony E Gregory, Barbara M Judy, Omar Qazi, et al.
Infection and Immunity|January 11, 2012
A double, long polar fimbria mutant of Escherichia coli O157:H7 expresses Curli and exhibits reduced in vivo colonizationSonja J Lloyd, Jennifer M Ritchie, Maricarmen Rojas-Lopez, et al.
Scientific Reports|March 8, 2014
Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infectionShane Massey, Linsey A Yeager, Carla A Blumentritt, et al.
BMC Microbiology|June 22, 2012
In vivo bioluminescence imaging of Escherichia coli O104:H4 and role of aerobactin during colonization of a mouse model of infectionAlfredo G Torres, Roberto J Cieza, Maricarmen Rojas-Lopez, et al.
Infection and Immunity|February 4, 2010
Testing the efficacy and toxicity of adenylyl cyclase inhibitors against enteric pathogens using in vitro and in vivo models of infectionScott T Moen, Carla A Blumentritt, Terry M Slater, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|June 26, 2013
Restrictive Streptomycin Resistance Mutations Decrease the Formation of Attaching and Effacing Lesions in Escherichia coli O157:H7 StrainsChun Chen, Carla A Blumentritt, Meredith M Curtis, et al.
Clinical and Vaccine Immunology : CVI|March 28, 2014
A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsisWildaliz Nieves, Hailey Petersen, Barbara M Judy, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 8, 2014
A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia malleiAnthony E Gregory, Barbara M Judy, Omar Qazi, et al.
Infection and Immunity|January 11, 2012
A double, long polar fimbria mutant of Escherichia coli O157:H7 expresses Curli and exhibits reduced in vivo colonizationSonja J Lloyd, Jennifer M Ritchie, Maricarmen Rojas-Lopez, et al.
Scientific Reports|March 8, 2014
Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infectionShane Massey, Linsey A Yeager, Carla A Blumentritt, et al.
BMC Microbiology|June 22, 2012
In vivo bioluminescence imaging of Escherichia coli O104:H4 and role of aerobactin during colonization of a mouse model of infectionAlfredo G Torres, Roberto J Cieza, Maricarmen Rojas-Lopez, et al.
Infection and Immunity|February 4, 2010
Testing the efficacy and toxicity of adenylyl cyclase inhibitors against enteric pathogens using in vitro and in vivo models of infectionScott T Moen, Carla A Blumentritt, Terry M Slater, et al.
Pageof 1